What is this test?
Full sequencing of BRCA1 and BRCA2 with deletion/duplication analysis (MLPA).
When is this test recommended?
Family history of breast/ovarian cancer, early-onset disease or male breast cancer.
Sample type
EDTA blood or saliva.
Genes analyzed
BRCA1, BRCA2.
Results
Identification of germline pathogenic variants linked to cancer risk.
Limitations
A negative result does not exclude all cancer risk.
Turnaround time
To Be Added
Required documents
To Be Added
Related diseases
Breast, ovarian, prostate, pancreatic cancers.